← FDA Drug Approvals (Drugs@FDA)

XELJANZ

NDA · New Drug Application · Sponsor: PFIZER · Approved 2020-09-25

Drug application

FDA Application #

NDA213082

Application type

New Drug Application

Brand name

XELJANZ

Generic name

TOFACITINIB

Active ingredients

TOFACITINIB CITRATE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

PFIZER

Manufacturer

Pfizer Laboratories Div Pfizer Inc

First approval

2020-09-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown